The National Committee for Quality Assurance is looking to change some quality measures it maintains for CMS for Medicare Advantage plans, and the healthcare accreditor wants public feedback on those revisions.
Detroit Medical Center is one of the first healthcare providers to use predictive analytics to better manage influenza patients at risk of driving up medical costs.
As more studies find longer-term consequences for even a mild concussion, including a heightened risk of suicide, the impact on sports continues to unfold.
Diagnostic errors are getting more attention. A coalition hopes to reduce the prevalence and cost of those errors through awareness and education.
Only 39% of hospitals that participated in the second model of Bundled Payments for Care Improvement continued in the model after they faced downside risk.
Healthcare quality analysts say favoritism toward incumbents and fear of disrupting the status quo are major reasons why the same groups are repeatedly selected to develop and maintain quality measures for the CMS.
The CMS' long-standing hospital readmissions penalty program has taken quite a beating recently from members of the research community over problems with its underlying measures.
Looking at how data can improve healthcare — both at a macro and micro level — has been a strategy at Medtronic for more than 60 years. Darrell Johnson, vice president of data science at Medtronic, discusses the near- and long-term benefits of data-driven solutions for clinicians and...
Advocates hired by patients are becoming more popular as a means to navigate the healthcare system.
Once considered the arbiter of patient complaints, the role of the patient advocate has expanded as navigating the healthcare system has become increasingly complex.
Doctors who specialize in female pelvic medicine say lawsuits by four states over products used to treat pelvic floor disorders might scare patients away from the best treatment options.
The National Institutes of Health is pushing for development of what its director has called a "pain-o-meter." Spurred by the opioid crisis, the goal isn't just to signal how much pain someone's in. It's also to determine what kind it is and what drug might be the most effective.